INFLAMMATION IN RESISTANCE TO BACTERIAL INFECTION
抵抗细菌感染的炎症
基本信息
- 批准号:3131355
- 负责人:
- 金额:$ 7.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1984
- 资助国家:美国
- 起止时间:1984-07-01 至 1990-06-30
- 项目状态:已结题
- 来源:
- 关键词:Listeria infections T lymphocyte bactericidal immunity cell type cellular immunity complement dairy products disease /disorder model food chain contamination gene expression inflammation laboratory mouse macrophage microorganism genetics monoclonal antibody neutrophil passive immunization phagocytes spleen transplantation
项目摘要
Infections caused by facultative intracellular pathogens continue
to be a significant health problem in the United States and
througout the world. Immunotherapeutic strategies for
combatting these infections would therefore be of considerable
benefit. Murine listeriosis has proven to be a convenient,
reproducible, and extremely informative laboratory model for
studying immuno-regulation of resistance to infection by
facultative intracellular pathogens. Considerable evidence has
been provided by our laboratory and others linking anti-listeria
resistance with the host's ability to rapidly mobilize an adequate
inflammatory response against the invading bacteria. The dual
role of T lymphocytes in the regulation of inflammatory
responsiveness and antibacterial resistance has been indicated by
adpotive transfer studies of listeria-immune T cells which showed
that L3T4+ T cells mediate accumulation of inflammatory cells in
vivo and Lyt2+ T cells are required for expression of antibacterial
resistance. Although these studies have been quite informative,
they fail to demonstrate the cellular interactions that occur in
vivo when an individual first encounters an invading facultative
intracellular pathogen. In the proposed study we will manipulate
mouse T cell subsets in vivo by administration of monoclonal anti-
L3T4 and anit Lyt2 antibodies and then determine the effect of
these treatments on inflammatory responsiveness and
antibacterial resistance. Soluble factors produced by these T
cells will be assessed for their pro-inflammatory effects in vivo
and for their influence on macrophage antibacterial activity in
vitro. The possible cytotoxic actio of listeria-immune Lyt2+ T
cells against literia-infected macrophages will be investigated as
a potential mechanism explaining the protection mediated by
these cells in vivo. Besides providing information that will
further illuminate our general understanding of T cell-mediated
resistance to facultative pathogens, the resuslts of this project
will also be germane to the pathogenesis of human listeriosis,
which has rapidly emerged as a significant public health problem
due to ingestion of listeria-contaminated dairy products.
由兼性细胞内病原体引起的感染继续存在
在美国是一个严重的健康问题,
离开这个世界。 免疫策略
因此,与这些感染作斗争将具有相当大的意义。
效益 小鼠骨髓增生已被证明是一种方便,
可重复的,非常翔实的实验室模型,
研究免疫调节对感染的抵抗力,
兼性细胞内病原体。 相当多的证据已
由我们的实验室和其他人提供,
抵抗与宿主的能力,迅速动员足够的
对入侵细菌的炎症反应。 双
T淋巴细胞在炎症调节中的作用
反应性和抗菌耐药性已被表明
免疫T细胞的适应性转移研究表明,
L3 T4 + T细胞介导炎性细胞的积聚,
体内和Lyt 2 + T细胞是表达抗菌素所必需的。
阻力 虽然这些研究提供了相当多的信息,
它们无法证明细胞间的相互作用,
当个体第一次遇到入侵的兼性
胞内病原体 在拟议的研究中,我们将操纵
小鼠体内T细胞亚群的单克隆抗-
L3 T4和抗Lyt 2抗体,然后确定
这些治疗对炎症反应的影响,
抗菌抗性 这些T细胞产生的可溶性因子
将评估细胞的体内促炎作用
以及它们对巨噬细胞抗菌活性的影响
体外 大肠杆菌免疫Lyt 2 + T细胞的细胞毒作用
将研究细胞对抗感染了大肠杆菌的巨噬细胞,
一种潜在的机制,解释了
这些细胞在体内。 除了提供信息,
进一步阐明了我们对T细胞介导的
对兼性病原体的抗性,该项目的恢复
也将与人类乳腺癌的发病机制密切相关,
这已经迅速成为一个重大的公共卫生问题
是因为摄入了受沙门氏菌污染的乳制品
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLES Joseph CZUPRYNSKI其他文献
CHARLES Joseph CZUPRYNSKI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLES Joseph CZUPRYNSKI', 18)}}的其他基金
Reducing wound bioburden and biofilm formation using a nanoscale wound surface en
使用纳米级伤口表面减少伤口生物负载和生物膜形成
- 批准号:
8386272 - 财政年份:2012
- 资助金额:
$ 7.97万 - 项目类别:
Reducing wound bioburden and biofilm formation using a nanoscale wound surface en
使用纳米级伤口表面减少伤口生物负荷和生物膜形成
- 批准号:
8518098 - 财政年份:2012
- 资助金额:
$ 7.97万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 7.97万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 7.97万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 7.97万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 7.97万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 7.97万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 7.97万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 7.97万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 7.97万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 7.97万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 7.97万 - 项目类别:
Discovery Grants Program - Individual